39 results
Page 2 of 2
8-K
EX-99.2
jygco14me0n92bx 1nbr
7 May 20
Ovid Therapeutics Reports First Quarter 2020 Financial Results and Provides Corporate Update
8:10am
8-K
EX-99.1
2tjuhs xs
13 Jul 18
Ovid Therapeutics Announces Initiation of Phase 2 ROCKET Clinical Trial to Evaluate OV101 in Fragile X Syndrome
9:22pm
10-K
xpx3r4bpd
29 Mar 18
Annual report
12:00am
10-K
EX-10.19
kl5jv mz0
29 Mar 18
Annual report
12:00am
10-Q
4rd3vj ayimx
13 Jun 17
Quarterly report
12:00am